van den Anker JN - Search Results

1

Renal drug clearance in preterm neonates: relation to prenatal growth.

Allegaert K, Anderson BJ, van den Anker JN, Vanhaesebrouck S, de Zegher F. Allegaert K, et al. Among authors: van den anker jn. Ther Drug Monit. 2007 Jun;29(3):284-91. doi: 10.1097/FTD.0b013e31806db3f5. Ther Drug Monit. 2007. PMID: 17529884

2

Developing an assay for ceftazidime: is it worth the effort?

van den Anker J. van den Anker J. Ther Drug Monit. 2011 Feb;33(1):132. doi: 10.1097/FTD.0b013e3181fd4c42. Ther Drug Monit. 2011. PMID: 21233691 No abstract available.

3

Is there really a need to adjust gentamicin dosing in neonates treated with hypothermia?

Samiee S, van den Anker J. Samiee S, et al. Ther Drug Monit. 2013 Dec;35(6):872. doi: 10.1097/FTD.0b013e318296bcfe. Ther Drug Monit. 2013. PMID: 24263645 No abstract available.

4

Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.

van den Anker JN. van den Anker JN. Ther Drug Monit. 2006 Dec;28(6):816; author reply 816-7. doi: 10.1097/01.ftd.0000249946.20294.59. Ther Drug Monit. 2006. PMID: 17164701 No abstract available.

5

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.

Anderson BJ, Allegaert K, Van den Anker JN, Cossey V, Holford NH. Anderson BJ, et al. Among authors: van den anker jn. Br J Clin Pharmacol. 2007 Jan;63(1):75-84. doi: 10.1111/j.1365-2125.2006.02725.x. Epub 2006 Jul 21. Br J Clin Pharmacol. 2007. PMID: 16869817 Free PMC article.

6

Thoughts on "Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates".

de Hoog M, Mouton JW, van den Anker JN. de Hoog M, et al. Among authors: van den anker jn. Ther Drug Monit. 2003 Apr;25(2):256-7; author reply 257. doi: 10.1097/00007691-200304000-00020. Ther Drug Monit. 2003. PMID: 12657925 No abstract available.

7

Vancomycin: pharmacokinetics and administration regimens in neonates.

de Hoog M, Mouton JW, van den Anker JN. de Hoog M, et al. Among authors: van den anker jn. Clin Pharmacokinet. 2004;43(7):417-40. doi: 10.2165/00003088-200443070-00001. Clin Pharmacokinet. 2004. PMID: 15139793 Review.

8

Dosing Guidelines of Aminoglycosides in Neonates: A Balance Between Physiology and Feasibility.

Allegaert K, Cossey V, van den Anker JN. Allegaert K, et al. Among authors: van den anker jn. Curr Pharm Des. 2015;21(39):5699-704. doi: 10.2174/1381612821666150901110659. Curr Pharm Des. 2015. PMID: 26323409 Review.

9

Educational paper: do we need neonatal clinical pharmacologists?

Allegaert K, Langhendries JP, van den Anker JN. Allegaert K, et al. Among authors: van den anker jn. Eur J Pediatr. 2013 Apr;172(4):429-35. doi: 10.1007/s00431-012-1734-4. Epub 2012 May 16. Eur J Pediatr. 2013. PMID: 22588521 Free PMC article. Review.

10

Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method.

Allegaert K, Kuppens M, Mekahli D, Levtchenko E, Vanstapel F, Vanhole C, van den Anker JN. Allegaert K, et al. Among authors: van den anker jn. J Matern Fetal Neonatal Med. 2012 Sep;25(9):1678-81. doi: 10.3109/14767058.2012.657277. Epub 2012 Feb 14. J Matern Fetal Neonatal Med. 2012. PMID: 22273037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results